Macular Degeneration Clinical Trials

Find clinical trials for macular degeneration. Search for macular degeneration clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 69

Observational StudyAge-related Macular Degeneration (AMD) and Cardiovascular Disease

Recruiting

Sponsor:

The New York Eye & Ear Infirmary

Location:

New York NY

Code:

NCT04087356

Conditions

Age-related Macular Degeneration

Coronary Artery Disease

Cardiovascular Diseases

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Blood draw

Observational StudyHome OCT Fluid Visualization Agreement Study

Recruiting

Sponsor:

Notal Vision Inc.

Location:

Marietta GA, Lexington KY, Glen Burnie MD, Boston MAshow 3 more

Code:

NCT04907409

Conditions

Neovascular Age-related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

IptacopanA Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Recruiting

PHASE2

Sponsor:

Novartis Pharmaceuticals

Location:

Fullerton CA, Huntington Beach CA, Rancho Cordova CA, Sacramento CAshow 20 more

Code:

NCT05230537

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Iptacopan (LNP023)

Placebo

Observational StudyAdaptive Optics Imaging of Outer Retinal Diseases

Recruiting

Sponsor:

Food and Drug Administration (FDA)

Location:

Bethesda MD, Silver Spring MD

Code:

NCT05355415

Conditions

Retinal Degeneration

Age-Related Macular Degeneration

Retinitis Pigmentosa

Hydroxychloroquine Retinopathy

Usher Syndromes

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Adaptive optics imaging

Observational StudyFactors in Learning and Plasticity: Healthy Vision

Recruiting

Sponsor:

University of Alabama at Birmingham

Location:

Birmingham AL, Riverside CA

Code:

NCT05439759

Conditions

Central Visual Impairment

Macular Degeneration

Eligibility Criteria

Sex: All

Age: 18 - 30

Healthy Volunteers: Accepted

Interventions

Condition 1: Training visual sensitivity

Condition 2: Training spatial integration

Condition 3: Training spatial attention

Condition 4: Combination training

Triamcinolone with RanibizumabSub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

Recruiting

PHASE2

Sponsor:

University Health Network, Toronto

Location:

Toronto

Code:

NCT01249937

Conditions

Wet Macular Degeneration

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ranibizumab

Triamcinolone Acetonide

SING-IMTMulticenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Recruiting

Sponsor:

VisionCare, Inc.

Location:

Loma Linda CA, Long Beach CA, Sarasota FL, Lawrence MAshow 6 more

Code:

NCT05438732

Conditions

Age-Related Macular Degeneration

Geographic Atrophy

Eligibility Criteria

Sex: All

Age: 65+

Healthy Volunteers: Not accepted

Interventions

smaller incision, new generation implantable miniature telescope (SING-IMT)

Kamuvudine-8Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Recruiting

PHASE1

PHASE2

Sponsor:

University of Kentucky

Location:

Lexington KY, Portland ME, Eugene OR, Sioux Falls SDshow 1 more

Code:

NCT06164587

Conditions

Geographic Atrophy

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

SKG0106A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Recruiting

Sponsor:

Skyline Therapeutics

Location:

Boston MA, Katy TX, Norfolk VA

Code:

NCT06346600

Conditions

Neovascular (Wet) Age-related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

SKG0106

SKG0106Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Recruiting

PHASE1

PHASE2

Sponsor:

Skyline Therapeutics (US) Inc.

Location:

Saint Petersburg FL, Boston MA, Katy TX, Norfolk VA

Code:

NCT05986864

Conditions

Neovascular Age-related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

SKG0106